Fig. 5From: Development and validation of a novel competing risk model for predicting survival of esophagogastric junction adenocarcinoma: a SEER population-based study and external validationa AUC of the Nomogram and 8th TNM Stage in prediction of prognosis of the validation cohort patients from 1-year to 10-year point. b The calibration curves for predicting patient survival of the validation cohort at 1-, 3-, 5-year, 7-year, 10-year pointBack to article page